STERIS plc

STE

$224.86

-0.87%

2026-09-04 11:46:15 EDT-$1.98

Salud

Médico - Especialidades

NYSE

Negociación activa

STERIS plc proporciona productos y servicios de prevención de infecciones en los Estados Unidos, Irlanda e internacionalmente. La empresa opera a través ...

Evolución del precio de STE

$224.86

-0.87%-$1.98

Máximo—

Mínimo—

Máx. 52s-16.1%

Vol. rel.—

Intervalo

Rango53m

Volumen—SMA5SMA10

—

STERIS plc, headquartered in Dublin, Ireland, operates globally with a workforce of over 18,000 employees across more than 100 countries. The company is structured into three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. It offers a wide range of products including cleaning chemistries, sterility assurance products, automated endoscope reprocessing ...STERIS plc, headquartered in Dublin, Ireland, operates globally with a workforce of over 18,000 employees across more than 100 countries. The company is structured into three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. It offers a wide range of products including cleaning chemistries, sterility assurance products, automated endoscope reprocessing systems, surgical tables, lights, and connectivity solutions. Additionally, STERIS provides essential services such as equipment maintenance, instrument repair, and contract sterilization for medical device and pharmaceutical manufacturers. The company is a key player in the medical specialties industry, with a market capitalization of approximately $23.1 billion. Financially, STERIS demonstrates robust margins: gross profit margin at 44.4%, operating profit margin at 18.9%, and net profit margin at 13.3%. It has a strong balance sheet with a current ratio of 5.886 and a quick ratio of 2.96, reflecting solid liquidity. With a price-to-earnings ratio of 28.96, the company is valued for its growth potential, and it pays a dividend yield of 1.1%. STERIS has a rich history, founded in 1985 as Innovative Medical Technologies and renamed in 1987, with roots tracing back to the American Sterilizer Company founded in 1894. Leadership under President and CEO Daniel A. Carestio since July 2021 has continued to drive innovation in infection prevention, ensuring patient safety and operational efficiency for healthcare providers worldwide.ExpandirContraer

Fundación

1985

Empleados

17937

CEO

Daniel A. Carestio

Nombre completo

STERIS plc

Sector

Salud

Industria

Médico - Especialidades

ROE

11.27%

Capitalización

$21.91B

Ratio corriente

1.91

WACC

8.37%

ROIC

9.30%

Información de contacto

https://www.steris.com

353 1 232 2000

5960 Heisley Road, Mentor, OH 44060

Métricas clave de STE

Instantánea

Último / TTM · 6 periodos

Capitalización

$21.91B

ROCE

12.1%

EV / EBITDA

13.07x

+0.6% YoY

Rendimiento FCF

4.2%

-0.3% YoY

Ciclo de conversión de efectivo

101.3d

Ratio corriente

1.91

Resumen rápido

TTM —

Positive CCC

Aspectos financieros de STE

Tendencia de rentabilidad

Último / TTM · 6 periodos

Margen bruto

44.4%

Margen neto

13.3%

PER

27.66x

n/d

Deuda / capital

0.28

n/d

Ratio corriente

1.91

Rendimiento del dividendo

1.1%

Comprensión

TTM —

Estos ratios principales no muestran una presión relevante en el balance.

Calendario de STE

Próximamente

4 sept 2026Hoy
Fecha ex-dividendo
$2.52 por acción
25 sept 2026En 21 días
Pago de dividendo
$2.52 por acción
30 dic 2026
Q3 FY2027 · Resultados estimados
BPA est. $2.81 · Ingresos $1.61B · 4 analistas
30 mar 2027
Q4 FY2027 · Resultados estimados
BPA est. $3.15 · Ingresos $1.71B · 1 analistas

Historial reciente

7 ago 2026
Q1 FY2027 · Resultados publicados
BPA $2.04 · Ingresos $1.49B
Ver documento
29 may 2026
FY2026 · Resultados anuales
BPA $7.93 · Ingresos $5.94B
Ver documento
6 feb 2026
Q3 FY2026 · Resultados publicados
BPA $1.96 · Ingresos $1.50B
Ver documento
6 nov 2025
Q2 FY2026 · Resultados publicados
BPA $1.94 · Ingresos $1.46B
Ver documento
7 ago 2025
Q1 FY2026 · Resultados publicados
BPA $1.79 · Ingresos $1.39B
Ver documento
29 may 2025
FY2025 · Resultados anuales
BPA $6.20 · Ingresos $5.46B
Ver documento

Estados financieros de STE

Tendencia de 5 años (ingresos, beneficios, FCF)

Métrica	Último	InteranualYoY significa Year-over-Year (interanual). Compara el último valor anual con el valor anual anterior para mostrar la fortaleza de la tendencia a largo plazo.	TrimestralQoQ significa Quarter-over-Quarter (intertrimestral). Compara el último trimestre con el trimestre inmediatamente anterior para mostrar cambios de impulso a corto plazo.
IngresosEl dinero total que entró por la puerta principal al vender cosas, antes de pagar una sola factura. Piensa en esto como el gran total de cada compra con tarjeta de los clientes. (YoY compara el rendimiento de este año con el del año pasado, mientras que QoQ compara los tres meses actuales con los tres anteriores).	$5.9B	+8.7%	-6.0%
Beneficio netoEl resultado final absoluto. Si la empresa pagara a cada proveedor, empleado, banquero y recaudador de impuestos, este es el dinero real que queda en su bolsillo al final del día.	$785.1M	+27.7%	-9.2%
Margen brutoEl margen básico. Si venden unas zapatillas de 100 dólares, este porcentaje indica cuánto de ese precio es ganancia justo después de pagar el caucho y los cordones, pero antes de pagar el alquiler de la tienda o los anuncios de televisión.	+44.2%	+0.5%	+4.4%
Margen operativoLa puntuación de eficiencia del 'trabajo diario'. De cada dólar que gasta un cliente, esto muestra cuántos centavos mantiene la empresa después de fabricar el producto Y pagar todos los gastos generales corporativos (como salarios, marketing y mantener las luces encendidas).	+18.6%	+16.9%	-4.0%
Margen netoEl porcentaje final que se lleva a casa. Cuando se eliminan todos los costos concebibles, impuestos y pagos de intereses, este es el número exacto de centavos que la empresa realmente se queda de cada dólar en ventas.	+13.2%	+17.5%	-3.3%
Flujo de caja libreEl santo grial del efectivo corporativo. Es el dinero físico gastable que queda después de que el negocio paga sus operaciones diarias Y compra las actualizaciones grandes y costosas (como nuevas fábricas o servidores) que necesita para sobrevivir. Este es el dinero 'libre' que pueden usar para pagar dividendos o recomprar acciones.	$972.4M	+25.0%	+14.0%
Margen FCFLa tasa definitiva de conversión de efectivo. Muestra qué tan buena es la empresa para convertir ventas regulares directamente en efectivo frío, duro y gastable. Un porcentaje alto significa que el negocio es una auténtica máquina de imprimir dinero.	+16.4%	+15.0%	+21.3%
Deuda/PatrimonioEl indicador de riesgo financiero. Compara cuánto del imperio de la empresa se construyó con dinero prestado (préstamos) frente al dinero propio de los propietarios (accionistas). Un número alto significa que están muy apalancados y juegan un juego más arriesgado; un número bajo significa que juegan a lo seguro.	29.1%	-12.9%	-2.4%
Ratio corrienteLa verificación de supervivencia de 12 meses. Simplemente compara el efectivo que tienen ahora mismo (más cosas que pueden convertirse rápidamente en efectivo) con las facturas inmediatas que absolutamente deben pagar este año. Una puntuación superior a 1 significa que tienen suficiente en la billetera para cubrir las próximas facturas sin entrar en pánico.	2.09x	+6.8%	-8.9%
Activos totalesEl tamaño absoluto del imperio de la empresa. Agrupa absolutamente todo lo valioso que poseen, desde el efectivo en la caja registradora y el inventario en el almacén, hasta las patentes de software en la bóveda y las fábricas en el suelo.	$10.7B	+5.8%	-0.0%

Real vs estimado

A Mar 31Q Dec 30

Métrica	Anual (real vs estimado)	Sorpresa anual	Trimestral (real vs estimado)	Sorpresa trimestral
EPS Surprise	7.93 vs 10.20	-22.2%	2.04 vs 2.81	-27.4%
Revenue Surprise	$5.9B vs $5.9B	-0.1%	$1.5B vs $1.6B	-7.4%

Transacciones de insiders de STE

Compras (A)

Since Aug 10, 2026

Ventas (D)

Since Aug 10, 2026

Acciones mensuales compradas/vendidas con tendencia del precio de cierre (fuente diaria compartida)

Resumen de trading de insiders

Fecha	Ejecutivo	Cargo	Valor	Lado	Acciones	Precio
Aug 12, 2026	Sohi Mohsen	director	Ordinary Shares	A	4,058	$86.23
Aug 12, 2026	Sohi Mohsen	director	Ordinary Shares	D	4,058	$235.78
Aug 12, 2026	Sohi Mohsen	director	Director Stock Option (right to buy)	D	4,058	$86.23
Aug 10, 2026	Sohi Mohsen	director	Career Restricted Stock Units	A	1,229	—
Aug 10, 2026	Sohi Mohsen	director	Director Stock Option (right to buy)	A	1,099	$238.91

Transcripción de la llamada de resultados de STE

1 segmentos de transcripción

Q4 2026

Ponente desconocido

Operator: Good day, and welcome to the STERIS plc Fourth Quarter 2026 Financial Results Conference Call. [Operator Instructions] Please note this event is being recorded. I would now like to turn the conference over to Julie Winter, Investor Relations. Please go ahead. Julie Winter: Thank you, Chad, and good morning, everyone. Speaking on today's call will be Karen Burton, our Senior Vice President and CFO; and Dan Carestio, our President and CEO. And I do have a few words of caution before we open for comments. This webcast contains time-sensitive information that is accurate only as of today. Any redistribution, retransmission or rebroadcast of this call without the express written consent of STERIS is strictly prohibited. Some of the statements made during this review are or may be considered forward-looking statements. Many important factors could cause actual results to differ materially from those in the forward-looking statements, including, without limitation, those risk factors described in STERIS' securities filings. The company does not undertake to update or revise any forward-looking statements as a result of new information or future events or developments. STERIS' SEC filings are available through the company and on our website. In addition, on today's call, non-GAAP financial measures, including adjusted earnings per diluted share, adjusted operating income, constant currency organic revenue growth and free cash flow, will be used. Additional information regarding these measures, including definitions, is available in our press release as well as reconciliations between GAAP and non-GAAP financial measures. Non-GAAP financial measures are presented during this call with the intent of providing greater transparency to supplemental financial information used by management and the Board of Directors in their financial analysis and operational decision-making. With those cautions, I will hand the call over to Karen. Karen Burton: Thank you, Julie, and good morning, everyone. It is my pleasure to be with you this morning to review the highlights of our fourth quarter performance from continuing operations. As anticipated, we ended the strong year with a lighter fourth quarter. For the fourth quarter, total as reported revenue grew 7%. Constant currency organic revenue grew 5% in the quarter, driven by volume as well as 230 basis points of price. Gross margin for the quarter was 44%, down 30 basis points versus the prior year. We continue to realize positive pricing, which helped mitigate the impact of higher tariffs and inflation. EBIT margin for the quarter was 24.2% of revenue, a high for fiscal 2026. This was 60 basis points below the fourth quarter last year mainly driven by inflation and tariffs. Incremental tariffs impacted our fourth quarter by approximately $10 million which was below our expectations due to lower volumes in materials and products sourced from outside the U.S. The adjusted effective tax rate in the quarter was …

Equipo directivo de STE

10 directivos

Nombre	Cargo	Remuneración	Género	Año de nacimiento	Estado
Daniel A. Carestio	President, Chief Executive Officer & Director	USD 2,840,320	Male	1973	Active
Andrew Xilas	Senior Vice President & GM of Dental	USD 1,438,246	Male	1965	Active
John Adam Zangerle	Senior Vice President, General Counsel & Secretary	USD 1,126,142	Male	1967	Active
Karen L. Burton	Senior Vice President, Chief Financial Officer & Chief Accounting Officer	USD 1,039,232	Female	1968	Active
Cary L. Majors	Senior Vice President & President of Healthcare	USD 1,028,172	Male	1975	Active
Mary Clare Fraser	SVP & Chief Human Resources Officer	USD 854,779	Female	1970	Active
Julie Winter	Vice President of Investor Relations & Corporate Communications	—	Female	—	Active
Lindsey McGowan	VP, Chief Compliance & Quality Officer	—	Female	—	Active
Kenneth E. Kohler	Senior Vice President & GM of AST	—	Male	1963	Active
Julia K. Madsen	Senior Vice President & GM of Life Sciences	—	Female	1965	Active

Noticias recientes de STE

Seeking Alpha6/8/2026Neutral

STERIS plc (STE) Q1 2027 Earnings Call Transcript

Zacks Investment Research6/8/2026Neutral

STE Q1 Earnings Beat, Revenues Miss, Stock Dips in Aftermarket Trading

STERIS beats fiscal Q1 earnings estimates as sales rise 7.3%, but a modest revenue miss sends shares 2.4% lower after hours.

Zacks Investment Research6/8/2026Neutral

5 Quality Stocks Set to Reward Investors With Dividend Hikes

Recent dividend hikes from DRH, STE, BCC, KWR and WHD highlight financially solid companies as investors seek stability in a mixed market.

Zacks Investment Research5/8/2026Neutral

Here's What Key Metrics Tell Us About Steris (STE) Q1 Earnings

While the top- and bottom-line numbers for Steris (STE) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Zacks Investment Research5/8/2026Neutral

Steris (STE) Q1 Earnings Surpass Estimates

Steris (STE) came out with quarterly earnings of $2.59 per share, beating the Zacks Consensus Estimate of $2.54 per share. This compares to earnings of $2.34 per share a year ago.

Evolución del número de empleados de STE

Actual

17,937

Cambio

-0.35%

Mínimo

16,000

Máximo

18,179

Presentaciones recientes

Fecha del informe	Empleados	Tipo de formulario	Fecha de presentación	Archivo SEC
31 mar 2026	17,937	10-K	29 may 2026	Ver
31 mar 2025	18,000	10-K	29 may 2025	Ver
31 mar 2024	18,179	10-K	29 may 2024	Ver
31 mar 2023	17,000	10-K	26 may 2023	Ver
31 mar 2022	16,000	10-K	31 may 2022	Ver

Acciones relacionadasMedical - Specialties

Ver todas las acciones de EE. UU. →

Sobre nosotrosPolítica de privacidadTérminos de servicioAviso legalDirectorio de accionesETFÍndicesCarteras 13FPrecios objetivoHerramientas gratuitasMapa tecnológicoÚnete a nuestro Slack

Plutux no es un asesor de inversiones. Los datos de mercado y el análisis generado por IA son solo informativos y educativos, no asesoramiento de inversión. Aviso legal

STERIS plc